Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3297927010 | Oral form isoniazid + pyrazinamide + rifampicin (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3298032011 | Oral form isoniazid + pyrazinamide + rifampicin | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488466010 | Product containing isoniazid and pyrazinamide and rifampicin in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497408012 | Product containing isoniazid and pyrazinamide and rifampicin in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497409016 | Isoniazid and pyrazinamide and rifampin in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497410014 | Isoniazid and pyrazinamide and rifampicin in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497411013 | Product containing isoniazid and pyrazinamide and rifampin in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3710481019 | Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3710482014 | Isoniazid- and pyrazinamide- and rifampin-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3710483016 | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | Isoniazid- and pyrazinamide- and rifampicin-containing product | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | Isoniazid- and rifampicin-containing product in oral dose form | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Has active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 2 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Has active ingredient | Isoniazid | true | Inferred relationship | Some | 3 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | Pyrazinamide-containing product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Isoniazid and pyrazinamide and rifampicin only product in oral dose form | Is a | True | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Inferred relationship | Some | |
| Isoniazid 50 mg and pyrazinamide 300 mg and rifampicin 120 mg oral tablet | Is a | False | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Inferred relationship | Some | |
| Ethambutol- and isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | True | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR